FOLFOX2 regimen in the treatment of advanced colorectal cancer: A comparison between elderly and young patients [5]

Annals of Oncology

Volumn 17, Issue 10, 2006, Pages 1606-1607

  Berretta, M ^a   Bearz, A ^a   Frustaci, S ^a   Buonadonna, A ^a   La Mura, N ^a   Malaguarnera, M ^b   Fulvi, A ^b   Shehu, I ^a   Tirelli, U ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADULT; AGED; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL PROTOCOL; COLORECTAL CANCER; CONTROLLED STUDY; DEATH; DIARRHEA; DRUG DOSE REGIMEN; FEMALE; FOLLOW UP; HAND FOOT SYNDROME; HUMAN; LETTER; LIVER METASTASIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; NAUSEA AND VOMITING; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; FEASIBILITY STUDIES; FLUOROURACIL; HUMANS; LEUCOVORIN; MIDDLE AGED; ORGANOPLATINUM COMPOUNDS;

EID: 33749614859     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdl098     Document Type: Letter

References (5)

1. Kim JH, Oh DY, Kim YJ et al. Reduced dose intensity Folfox-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer. J Korean Med Sci 2005; 20: 806-810.
2. Berardi R, Saladino T, Mari D et al. Elderly patients with advanced colorectal cancer: Tolerability and activity of chemotherapy. Tumori 2005; 91: 463-466.
3. Comella P, Gambardella A, Farris A et al. A tailored regimen includine capecitabina and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma Southern Italy Cooperative Oncology trial 0108. Crit Rev Oncol Hematol 2005; 53: 133-139.
4. Raymond E, Buquet-Fagot C, Djelloul S et al. Antitumoral activity of oxaliplatin in combination with 5-fluorouracil and thymidase inhibitor AG337 in human colon, breast and ovarian cancers. Anticancer Drugs 1997; 8: 876-885.
5. de Gramont A, Vignoud J, Tourningand C et al. Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in preatreated metastatic CRC. Eur J Cancer 1997; 33: 214-219.